These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5783784)

  • 1. Haloperidol in the treatment of behavioural disorders in children and adolescents.
    Le Vann LJ
    Can Psychiatr Assoc J; 1969 Apr; 14(2):217-20. PubMed ID: 5783784
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol--a preliminary clinical study.
    Holstein AP; Chen CH
    Am J Psychiatry; 1965 Oct; 122(4):462-3. PubMed ID: 5825400
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: two case reports with a literature review.
    Geller B; Greydanus DE
    J Clin Psychiatry; 1979 Feb; 40(2):102-3. PubMed ID: 762029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot evaluation of Orap (pimozide, R 6238) in child psychiatry.
    Pangalila-Ratulangi EA
    Psychiatr Neurol Neurochir; 1973; 76(1):17-27. PubMed ID: 4572950
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of propericiazine on behavior disorders of children and adolescents].
    Duche DJ
    Laval Med; 1970 Jun; 41(6):784-8. PubMed ID: 4396436
    [No Abstract]   [Full Text] [Related]  

  • 6. Haloperidol for psychiatric disorders in children.
    Serrano AC; Forbis OL
    Dis Nerv Syst; 1973; 34(5):226-31. PubMed ID: 4273764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia].
    Semanovskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1529-34. PubMed ID: 4386295
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 2).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Mar; 25(3):143-6. PubMed ID: 2868821
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical comparison of haloperidol with chlorpromazine in mentally retarded children.
    Le Vann LJ
    Am J Ment Defic; 1971 May; 75(6):719-23. PubMed ID: 4932179
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.
    McAndrew JB; Case Q; Treffert DA
    J Autism Child Schizophr; 1972; 2(1):75-91. PubMed ID: 5067403
    [No Abstract]   [Full Text] [Related]  

  • 11. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients.
    Malt UF; Nystad R; Bache T; Noren O; Sjaastad M; Solberg KO; Tønseth S; Zachariassen P; Maehlum E
    Br J Psychiatry; 1995 Mar; 166(3):374-7. PubMed ID: 7788130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liothyronine treatment in psychotic and nonpsychotic children under 6 years.
    Campbell M; Fish B; David R; Shapiro T; Collins P; Koh C
    Arch Gen Psychiatry; 1973 Nov; 29(5):602-8. PubMed ID: 4589808
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiothixene in young disturbed children. A pilot study.
    Campbell M; Fish B; Shapiro T; Floyd A
    Arch Gen Psychiatry; 1970 Jul; 23(1):70-2. PubMed ID: 5447378
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
    Luckey WT; Schiele BC
    Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 17. A rating scale for extrapyramidal side effects.
    Simpson GM; Angus JW
    Acta Psychiatr Scand Suppl; 1970; 212():11-9. PubMed ID: 4917967
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol in the treatment of children with severe behaviour disorders.
    Cunningham MA; Pillai V; Rogers WJ
    Br J Psychiatry; 1968 Jul; 114(512):845-54. PubMed ID: 4874166
    [No Abstract]   [Full Text] [Related]  

  • 19. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol for control of severe emotional reactions in mentally retarded patients.
    Grabowski SW
    Dis Nerv Syst; 1973; 34(6):315-7. PubMed ID: 4782288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.